Effect of premature infant oral motor intervention (PIOMI) and pacifier intervention on the transition to oral feeding in preterm infants: A randomized controlled study

早产儿口腔运动干预(PIOMI)和安抚奶嘴干预对早产儿过渡到经口喂养的影响:一项随机对照研究

阅读:1

Abstract

AIM: This study aimed to evaluate the effect of premature infant oral motor intervention (PIOMI) and pacifier intervention on the transition to full oral feeding in preterm infants. METHODS: This is a randomized controlled trial conducted between January 2021 and April 2023 in a neonatal intensive care unit in Eskişehir, Turkey. Preterm infants born between 29 and 34 weeks of gestation were included in the study. Infants were assigned to the groups by stratified randomization method. The study was completed with a total of 39 infants, 13 infants in each group (PIOMI, pacifier, and control). Data were collected using the "Preterm Infant Demographic Information Form," "Feeding Monitor Form," and "Early Feeding Skills Assessment Tool (EFS)." Statistical analysis used paired sample t-tests, ANOVA, Wilcoxon, Kruskal-Wallis H, and Pearson-χ(2) test methods. RESULTS: In the research findings, it was determined that infants receiving PIOMI and pacifier intervention had a shorter length of stay, transition to full oral feeding compared to infants in the control group, and consumed a higher amount of feed in the first minute (p < .05). The infants in the PIOMI group started full oral feeding on average 3 days earlier than the infants in the pacifier group and were discharged approximately 4 days earlier (p > .05). It was determined that infants in the PIOMI group had significantly higher EFS-total compared to infants in the control group. CONCLUSIONS: PIOMI intervention and pacifier intervention should be included in nursing care in neonatal intensive care units to improve the oral feeding skills of preterm infants and shorten their discharge time.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。